Susan Dorman, MD

Faculty

Titles:

Associate Professor, Medicine

SciVal:

SciVal Link

Dr. Dorman and her research team at JHU focus on the development and assessment of new tuberculosis diagnostic tests and strategies and new tuberculosis treatment strategies.  Her team’s multidisciplinary work in tuberculosis diagnostics includes test development, accuracy assessments, implementation research, economic evaluations, and mathematical modeling.  Dr. Dorman serves as co-Principal investigator with Dr. Jerrold Ellner on a U.S. National Institutes of Health-funded contract, the ‘Tuberculosis Clinical Diagnostics Research Consortium’, whose mission is to conduct early stage assessments of novel diagnostic tests for tuberculosis at study sites in China, South Korea, South Africa, Kenya, Uganda, and Brazil.  She also serves as Principal Investigator on phase I, II, and III clinical trials of rifapentine, including multicenter international trials of the CDC Tuberculosis Trials Consortium. 

Categories

Events

«

July 2018

»
S
M
T
W
T
F
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
·
·
·
·

Projects

A randomized trial of preventive therapy for...

We are evaluating the efficacy and cost-effectiveness of levofloxacin preventive therapy for pediatric contacts of MDR TB...

Read More

Assessing the social value of novel regimens...

We are collaborating with investigators from the Berman Bioethics Institute to develop novel techniques for economic evaluation...

Read More

Understanding the role of repeat testing and...

We have developed a Markov model of serial IGRA testing to help improve testing algorithms with TST vs. IGRA in low-risk...

Read More